Search Results - "Klasen, Ina S."

Refine Results
  1. 1
  2. 2

    Antibodies against the CUB1-2 domains of ADAMTS13 in a patient with benign monoclonal gammopathy: no causal relationship by Riksen, Niels P, Luken, Brenda M, Klasen, Ina S, Voorberg, Jan, Crama, Niels, van Deuren, Marcel

    Published in Haematologica (Roma) (01-06-2007)
    “…1 Department of Internal Medicine, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands 2 Department of Pharmacology-Toxicology, Radboud…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Plasmacytoid dendritic cells of melanoma patients present exogenous proteins to CD4+ T cells after Fc gamma RII-mediated uptake by Benitez-Ribas, Daniel, Adema, Gosse J, Winkels, Gregor, Klasen, Ina S, Punt, Cornelis J A, Figdor, Carl G, de Vries, I Jolanda M

    Published in The Journal of experimental medicine (10-07-2006)
    “…Plasmacytoid dendritic cells (pDCs) contribute to innate antiviral immune responses by producing type I interferons. Although human pDCs can induce T cell…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7

    Serum ferritin levels are increased in patients with glomerular diseases and proteinuria by Branten, Amanda J. W., Swinkels, Dorine W., Klasen, Ina S., Wetzels, Jack F. M.

    Published in Nephrology, dialysis, transplantation (01-11-2004)
    “…Background. Ferritin is a high molecular weight protein which reflects body iron stores, but may also rise in the case of an acute phase response. Recently,…”
    Get full text
    Journal Article
  8. 8

    Cerebrospinal fluid IgM index correlates with cranial MRI lesion load in patients with multiple sclerosis by Jongen, Peter J H, Lycklama a Nijeholt, Geert, Lamers, Karel J B, Doesburg, Wim H, Barkhof, Frederik, Lemmens, Wim A J G, Klasen, Ina S, Hommes, Otto R

    Published in European neurology (01-01-2007)
    “…In multiple sclerosis intrathecal IgM synthesis correlates with an unfavourable disease course. Whether this reflects a pathogenic role of IgM, possibly in…”
    Get more information
    Journal Article
  9. 9

    Hyper-immunoglobulin A in the hyperimmunoglobulinemia D syndrome by Klasen, I S, Göertz, J H, van de Wiel, G A, Weemaes, C M, van der Meer, J W, Drenth, J P

    “…The hyperimmunoglobulinemia D syndrome (HIDS) is an autosomal recessive disorder characterized by recurrent febrile attacks with abdominal, articular, and skin…”
    Get full text
    Journal Article
  10. 10

    The fractional excretion of soluble interleukin-2 receptor-α is an excellent predictor of the interleukin-2 receptor-α status after treatment with daclizumab by TER MEULEN, Cornelis G, JACOBS, Cor W. M, WETZELS, Jack F. M, KLASEN, Ina S, HILBRANDS, Luuk B, HOITSMA, Andries J

    Published in Transplantation (27-01-2004)
    “…Daclizumab is a humanized monoclonal antibody against the alpha-chain of the interleukin (IL)-2 receptor (R). The authors previously have shown that the…”
    Get full text
    Journal Article
  11. 11

    The gelatin-derived plasma substitute Gelofusine causes low-molecular-weight proteinuria by decreasing tubular protein reabsorption by ten Dam, Marc A.G.J., Branten, Amanda J.W., Klasen, Ina S., Wetzels, Jack F.M.

    Published in Journal of critical care (01-09-2001)
    “…Purpose: Proteinuria is frequently encountered in patients in the intensive care unit, most likely as a result of renal tubular cell injury. It has been…”
    Get full text
    Journal Article
  12. 12

    Decreased renal excretion of soluble interleukin-2 receptor α after treatment with daclizumab by ter Meulen, Cornelis G., Göertz, Joop H.C., Klasen, Ina S., Verweij, Carla M.T.A., Hilbrands, Luuk B., Wetzels, Jack F.M., Hoitsma, Andries J.

    Published in Kidney international (01-08-2003)
    “…Decreased renal excretion of soluble interleukin-2 receptor α after treatment with daclizumab. Daclizumab (±150 kD), a humanized monoclonal antibody (mAb)…”
    Get full text
    Journal Article
  13. 13
  14. 14
  15. 15

    Overestimation of Serum [kappa] Free Light Chain Concentration by Immunonephelometry by Angelino, Corrie M de Kat, Raymakers, Reinier, Teunesen, Maria A, Jacobs, Joannes F M, Klasen, Ina S

    Published in Clinical chemistry (Baltimore, Md.) (01-07-2010)
    “…Accurate quantification of sFLCs is important because it is one of the prognostic indicators at disease presentation. [...] the International MyelomaWorking…”
    Get full text
    Journal Article
  16. 16

    Overestimation of Serum [kappa] Free Light Chain Concentration by Immunonephelometry/In Reply by Mead, Graham P, Carr-Smith, Hugh D, Jacobs, Joannes F M, Angelino, Corrie M de Kat, Raymakers, Reinier, Klasen, Ina S

    Published in Clinical chemistry (Baltimore, Md.) (01-09-2010)
    “…All authors confirmed they have contributed to the intellectual content of this paper and have met the following 3 requirements: (a) significant contributions…”
    Get full text
    Journal Article
  17. 17

    Plasmacytoid dendritic cells of melanoma patients present exogenous proteins to CD4 super(+) T cells after Fc gamma RII-mediated uptake by Benitez-Ribas, Daniel, Adema, Gosse J, Winkels, Gregor, Klasen, Ina S, Punt, Cornelis JA, Figdor, Carl G, de Vries, IJolanda M

    Published in The Journal of experimental medicine (01-07-2006)
    “…Plasmacytoid dendritic cells (pDCs) contribute to innate antiviral immune responses by producing type I interferons. Although human pDCs can induce T cell…”
    Get full text
    Journal Article
  18. 18

    Urinary excretion of beta2-microglobulin and IgG predict prognosis in idiopathic membranous nephropathy: a validation study by Branten, Amanda J W, du Buf-Vereijken, Peggy W, Klasen, Ina S, Bosch, Frank H, Feith, Geert W, Hollander, Daan A, Wetzels, Jack F

    “…An accurate prediction of the prognosis of patients with idiopathic membranous nephropathy (iMN) should allow restriction of immunosuppressive treatment to…”
    Get full text
    Journal Article
  19. 19

    Decreased renal excretion of soluble interleukin-2 receptor after treatment with daclizumab by Ter Meulen, Cornelis G, Göertz, Joop H C, Klasen, Ina S, Carla M T A Verweij, Hilbrands, Luuk B, Wetzels, Jack F M, Hoitsma, Andries J

    Published in Kidney international (01-08-2003)
    “…Daclizumab (+/-150 kD), a humanized monoclonal antibody (mAb) against the alpha-chain of the membrane-bound interleukin-2 (IL-2) receptor (IL-2R) also binds…”
    Get full text
    Journal Article
  20. 20

    The fractional excretion of soluble interleukin-2 receptor-?? is an excellent predictor of the interleukin-2 receptor-?? status after treatment with daclizumab by ter Meulen, Cornelis G., Jacobs, Cor W. M., Wetzels, Jack F. M., Klasen, Ina S., Hilbrands, Luuk B., Hoitsma, Andries J.

    Published in Transplantation (27-01-2004)
    “…Background. Daclizumab is a humanized monoclonal antibody against the [alpha]-chain of the interleukin (IL)-2 receptor (R). The authors previously have shown…”
    Get full text
    Journal Article